Company intelligence / Profile preview
Carmell Corporation
Pittsburgh, Pennsylvania, United Statescarmellcosmetics.com ↗
- Ownership
- Public · CTCX
- Employees
- ~10
- Development stage
- Commercial
01
Overview
Carmell’s PBM platform delivers a cocktail of regenerative growth factors from allogeneic platelets to accelerate healing in bone and soft tissue. BHA has received FDA Fast Track status for open tibia fractures with ongoing clinical trials. The company also markets or plans to market cosmetic products leveraging its proprietary secretome technology for anti-aging skin care and hair regrowth. Early results suggest improved healing rates in orthopedic indications; cosmetic lines have shown positive user feedback but lack large-scale published clinical data yet[1][2][3].
- Therapeutic areas
- OtherDermatologyRheumatology
- Modalities
- Plasma-based bioactive materials (PBM)growth factors and proteins derived from allogeneic human plateletsnot small molecules or mAbs but rather biologically active biomaterials and secretomes[2][7]
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
No major pharma partnerships publicly disclosed as of May 2025.
04
Financials
- Market cap
- $5.9M
- Total revenue
- $396K
- Enterprise value
- $6.2M
Beyond the preview
Go deeper on Carmell Corporation.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Carmell Corporation.